(NASDAQ:GIFT), SCHAUMBURG, IL, Jan. 21, 2025 (GLOBE NEWSWIRE) — Giftify, Inc. (NASDAQ: GIFT) (the “Company”), the owner and operator of leading digital platforms, CardCash.com and Restaurant.com, with a focus on incentives and rewards in retail, dining and entertainment experiences, is pleased to provide the following strategic growth initiatives for Restaurant.com, the nation's largest restaurant-focused digital […]
SAN FRANCISCO, Jan. 21, 2025 (GLOBE NEWSWIRE) — New data from papers published in science and medical journals in 2024 shows tremendous growth in the evidence of efficacy of one particular brain fitness product: BrainHQ from Posit Science. The widely used web, Android, and iOS app was the subject of another 55 published journal articles
NIAGARA-ON-THE-LAKE, Ontario, Jan. 21, 2025 (GLOBE NEWSWIRE) — Southbrook Organic Vineyards, the acclaimed biodynamic winery pioneering natural, small-batch winemaking, proudly announces its release of a limited-edition wine collection signed by award-winning Canadian Chef Keith Pears, and Southbrook's founder, Bill Redelmeier. The Southbrook CHEFS CANADA Limited Edition Set marks the winery as the official wine partner
(NASDAQ:HUMA), – Plans for filing an IND was agreed with the FDA in a recent meeting – – Positive preclinical results of the small-diameter ATEV were recently presented at The American Heart Association's Scientific Sessions 2024 meeting – DURHAM, N.C., Jan. 21, 2025 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a biotechnology platform company developing
(Other OTC:AONC),(OTC US:AONC), FORT MYERS, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) — Florida Oncology and Hematology, a partner practice of American Oncology Network (AON), has relocated its clinic in Fort Myers to 14551 Hope Center Loop. The newly expanded clinic includes 12 exam rooms, nearly 30 infusion chairs, and an onsite lab. Current or prospective
(PinkSheets:EBYH),(Pinksheets:EBYH), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — Strainsforpains, Inc. fka/ E-Buy Home, Inc. (OTC: EBYH). Strainsforpains, Inc. is redefining the future of wellness, cannabis innovation, and AI integration. With a transformative year in the books, the company is poised to disrupt multiple industries and deliver groundbreaking results in 2025. Unparalleled Revenue Growth and
REDWOOD CITY, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) — The enterprise AI infrastructure and graph database leader TigerGraph today announced Savanna, the next generation cloud offering, extending its market leadership as the graph database designed for companies that need to quickly discover relationships, analyze complex patterns, and make mission critical decisions across large amounts of
(PinkSheets:VDRM),(Pinksheets:VDRM), LOS ANGELES, Jan. 21, 2025 (GLOBE NEWSWIRE) — ViaDerma, Inc. (OTC Pink: VDRM), an innovator in transdermal drug delivery and topical antibiotic products, is pleased to announce the opening of a satellite office in Dubai to facilitate its ongoing expansion in the Middle East. Local regulations require businesses to maintain a physical office within
(NasdaqGM:CRMD), BERKELEY HEIGHTS, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announces it has engaged with WSI PBG, a subsidiary of Golden State Medical Supply, to promote DefenCath(R) to healthcare providers in facilities operated by the
(NASDAQ:REPL), WOBURN, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for RP1 (vusolimogene oderparepvec) in combination with nivolumab for patients with advanced